MedPath

The Effect of Ajwain fruit extract on Improvement of Irritable Bowel Syndrome (IBS) Symptoms

Phase 2
Recruiting
Conditions
Irritable Bowel Syndrome (IBS).
Irritable bowel syndrome
Registration Number
IRCT20160306026938N8
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria

Adherence to diagnostic criteria of Irritable Bowel Syndrome (IBS) including recurrent abdominal pain at least three days in a month during past three months and beginning of symptoms at least from six months ago plus at least two conditions of three pain alleviation conditions after defecation, variations in number of defecation times and changes in stool consistency
Age range of 18-70 years old
Signing the informed consent

Exclusion Criteria

Being afflicted with any underlying disease
pregnancy
Being allergic to Apiaceae family plants
Bowel dysfunctions including abnormal colonoscopy observations
Lactation period
Consumption of medications for improvement of irritable bowel syndrome symptoms

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Abdominal pain. Timepoint: After intervention (one month after intervention). Method of measurement: Scoring patients based on a 0-10 Likert Scale with regard to improvements in symptoms (0=no improvement; 10= complete improvement).;Diarrhea. Timepoint: After intervention (one month after intervention). Method of measurement: Scoring patients based on a 0-10 Likert Scale with regard to improvements in symptoms (0=no improvement; 10= complete improvement).;Constipation. Timepoint: After intervention (one month after intervention). Method of measurement: Scoring patients based on a 0-10 Likert Scale with regard to improvements in symptoms (0=no improvement; 10= complete improvement).;Bloating. Timepoint: After intervention (one month after intervention). Method of measurement: Scoring patients based on a 0-10 Likert Scale with regard to improvements in symptoms (0=no improvement; 10= complete improvement).
Secondary Outcome Measures
NameTimeMethod
Quality of life score. Timepoint: Before intervention, 2 weeks after intervention, 4 weeks after study being initiated, 2 weeks after termination of the intervention. Method of measurement: Completing 34-item questionnaire of life quality among IBS patients (IBS_QOL34) by the patient himself.
© Copyright 2025. All Rights Reserved by MedPath